QA: ALIMERA SCIENCES INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001267602_2021_ALIMERA_SCIENCES_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001267602, ALIMERA SCIENCES INC

  xvar xval
0 AssetsCurrent 34,906,000
1 IntangibleAssetsNetIncludingGoodwill 12,838,000
2 PropertyPlantAndEquipmentNet 1,638,000
3 remainder_Assets 1,473,000
4 LiabilitiesCurrent 12,348,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,652,000
9 ResearchAndDevelopmentExpense 9,668,000
10 remainder_Expenses 35,313,000
11 remainder_Revenues 50,820,000
12 remainder_NetIncome 474,000
13 remainder_ComprehensiveNetIncome 540,000
  yvar yval
0 Assets 50,855,000
1 Liabilities 12,348,000
2 Expenses 56,633,000
3 Revenues 50,820,000
4 StockholdersEquity 38,507,000
5 NetIncome -5,339,000
6 ComprehensiveNetIncome -5,069,000
7 BaseVar 85,835,000
8 EconomicCapitalRatio 1.94

Edgar->Model Mapping

Feature Distribution

Change over Time